Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul;31(4):e2197.
doi: 10.1002/rmv.2197. Epub 2020 Nov 22.

Full-length genome sequencing of RNA viruses-How the approach can enlighten us on hepatitis C and hepatitis E viruses

Affiliations
Review

Full-length genome sequencing of RNA viruses-How the approach can enlighten us on hepatitis C and hepatitis E viruses

Elodie Laugel et al. Rev Med Virol. 2021 Jul.

Abstract

Among the five main viruses responsible for human hepatitis, hepatitis C virus (HCV) and hepatitis E virus (HEV) are different while sharing similarities. Both viruses can be transmitted by blood or derivatives whereas HEV can also follow environmental or zoonotic routes. These highly variable RNA viruses can cause chronic hepatitis potentially leading to hepatocarcinoma. HCV and HEV can develop new structures and functions under selective pressure to adapt to host immunity, human tissues, treatments or even various animal reservoirs. Elsewhere, with directly acting antiviral treatments, HCV can be eradicated whereas HEV is an emerging pathogen against which specific treatments have to be improved. As a unique molecular tool able to explore viral genomic plasticity, full-length genome (FLG) sequencing has become easier, faster and cheaper. The present review will show how FLG sequencing can explore these RNA viruses with the aim to investigate key genomics data to improve basic knowledge, patients' healthcare and preventive tools.

Keywords: RNA viruses; full-length genome; hepatitis C virus; hepatitis E virus.

PubMed Disclaimer

References

REFERENCES

    1. World Health Organization. World Health Organization, global hepatitis programme. Global hepatitis report. 2017. Retrieved from http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf?...
    1. Donnelly MC , Scobie L , Crossan CL , Dalton H , Hayes PC , Simpson KJ . Review article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy. Aliment Pharmacol Ther. 2017;46(2):126-141. https://doi.org/10.1111/apt.14109
    1. Razavi H . Global epidemiology of viral hepatitis. Gastroenterol Clin North Am. 2020;49(2):179-189. https://doi.org/10.1016/j.gtc.2020.01.001
    1. Choo Q , Kuo G , Weiner A , Overby L , Bradley D , Houghton M . Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989;244(4902):359-362. https://doi.org/10.1126/science.2523562.
    1. Gardner RC , Howarth AJ , Hahn P , Brown-Luedi M , Shepherd RJ , Messing J . The complete nucleotide sequence of an infectious clone of cauliflower mosaic virus by M13mp7 shotgun sequencing. Nucleic Acids Res. 1981;9(12):2871-2888. https://doi.org/10.1093/nar/9.12.2871

LinkOut - more resources